The Food and Drug Administration plans to look to some unusual allies to limit the flood of the addictive pills health insurers and companies that manage prescription drug benefits.
DebugScreen: mobile
{
"author": {
"name": "Anna Edney Bloomberg",
"webUrl": "/author/profile/anna-edney-bloomberg/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 1,
"social": [],
"articles": [
{
"uri": "/2017/07/24/trumps-fda-chief-takes-wide-aim-at-opioid-addictio/",
"title": "Trump's FDA chief takes wide aim at opioid addiction crisis",
"byline": " Anna Edney, Bloomberg ",
"kicker": "",
"prettyDate": "July 24, 2017",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/anna-edney-bloomberg/",
"name": "Anna Edney, Bloomberg"
}
],
"kickerNode": [],
"summary": "The Food and Drug Administration plans to look to some unusual allies to limit the flood of the addictive pills health insurers and companies that manage prescription drug benefits.",
"body": null
}
]
}
}